Ciongoli Gregory Austin

DirectorREGENXBIO Inc. (RGNX) · full profile →Form 4 · filed Aug 27, 2026
Net Buying
Open-Market Buys
$949K
Open-Market Sells
$0
Net Open-Market Flow
$949K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 27, 2026Buy(P)53K$9.36$500K118K
Aug 26, 2026Buy(P)49K$9.14$450K65K
Aug 25, 2026Grant(A)15K$015K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 25, 2026Grant(A)70K$070K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002023732-26-000008) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.